Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
This report aims to provide a comprehensive presentation of the global market for Hospital Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Injectable Drugs. This report contains market size and forecasts of Hospital Injectable Drugs in global, including the following market information:
Global Hospital Injectable Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hospital Injectable Drugs market was valued at US$ 41580 million in 2022 and is projected to reach US$ 56940 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
We surveyed the Hospital Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Injectable Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hospital Injectable Drugs Market Segment Percentages, by Type, 2022 (%)
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Global Hospital Injectable Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hospital Injectable Drugs Market Segment Percentages, by Application, 2022 (%)
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Global Hospital Injectable Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hospital Injectable Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Injectable Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital Injectable Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy?s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital Injectable Drugs, market overview.
Chapter 2: Global Hospital Injectable Drugs market size in revenue.
Chapter 3: Detailed analysis of Hospital Injectable Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital Injectable Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital Injectable Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Injectable Drugs Overall Market Size
2.1 Global Hospital Injectable Drugs Market Size: 2022 VS 2029
2.2 Global Hospital Injectable Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Injectable Drugs Players in Global Market
3.2 Top Global Hospital Injectable Drugs Companies Ranked by Revenue
3.3 Global Hospital Injectable Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hospital Injectable Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital Injectable Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Injectable Drugs Players in Global Market
3.6.1 List of Global Tier 1 Hospital Injectable Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Injectable Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Injectable Drugs Market Size Markets, 2022 & 2029
4.1.2 Generic Sterile Injectables
4.1.3 Sterile Intravenous (IV) Solutions
4.2 By Type - Global Hospital Injectable Drugs Revenue & Forecasts
4.2.1 By Type - Global Hospital Injectable Drugs Revenue, 2018-2023
4.2.2 By Type - Global Hospital Injectable Drugs Revenue, 2024-2029
4.2.3 By Type - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Injectable Drugs Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Anesthesia
5.1.4 Anti-Infectives
5.1.5 Parenteral Nutrition
5.1.6 Cardiovascular Diseases
5.2 By Application - Global Hospital Injectable Drugs Revenue & Forecasts
5.2.1 By Application - Global Hospital Injectable Drugs Revenue, 2018-2023
5.2.2 By Application - Global Hospital Injectable Drugs Revenue, 2024-2029
5.2.3 By Application - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hospital Injectable Drugs Market Size, 2022 & 2029
6.2 By Region - Global Hospital Injectable Drugs Revenue & Forecasts
6.2.1 By Region - Global Hospital Injectable Drugs Revenue, 2018-2023
6.2.2 By Region - Global Hospital Injectable Drugs Revenue, 2024-2029
6.2.3 By Region - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hospital Injectable Drugs Revenue, 2018-2029
6.3.2 US Hospital Injectable Drugs Market Size, 2018-2029
6.3.3 Canada Hospital Injectable Drugs Market Size, 2018-2029
6.3.4 Mexico Hospital Injectable Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hospital Injectable Drugs Revenue, 2018-2029
6.4.2 Germany Hospital Injectable Drugs Market Size, 2018-2029
6.4.3 France Hospital Injectable Drugs Market Size, 2018-2029
6.4.4 U.K. Hospital Injectable Drugs Market Size, 2018-2029
6.4.5 Italy Hospital Injectable Drugs Market Size, 2018-2029
6.4.6 Russia Hospital Injectable Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Hospital Injectable Drugs Market Size, 2018-2029
6.4.8 Benelux Hospital Injectable Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hospital Injectable Drugs Revenue, 2018-2029
6.5.2 China Hospital Injectable Drugs Market Size, 2018-2029
6.5.3 Japan Hospital Injectable Drugs Market Size, 2018-2029
6.5.4 South Korea Hospital Injectable Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Hospital Injectable Drugs Market Size, 2018-2029
6.5.6 India Hospital Injectable Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hospital Injectable Drugs Revenue, 2018-2029
6.6.2 Brazil Hospital Injectable Drugs Market Size, 2018-2029
6.6.3 Argentina Hospital Injectable Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Injectable Drugs Revenue, 2018-2029
6.7.2 Turkey Hospital Injectable Drugs Market Size, 2018-2029
6.7.3 Israel Hospital Injectable Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Hospital Injectable Drugs Market Size, 2018-2029
6.7.5 UAE Hospital Injectable Drugs Market Size, 2018-2029
7 Hospital Injectable Drugs Companies Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Company Summary
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Major Product Offerings
7.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.1.5 Hospira (Pfizer Inc.) Key News & Latest Developments
7.2 Baxter
7.2.1 Baxter Company Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Hospital Injectable Drugs Major Product Offerings
7.2.4 Baxter Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.2.5 Baxter Key News & Latest Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Summary
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Hospital Injectable Drugs Major Product Offerings
7.3.4 Fresenius Kabi Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.3.5 Fresenius Kabi Key News & Latest Developments
7.4 Sandoz (Novartis)
7.4.1 Sandoz (Novartis) Company Summary
7.4.2 Sandoz (Novartis) Business Overview
7.4.3 Sandoz (Novartis) Hospital Injectable Drugs Major Product Offerings
7.4.4 Sandoz (Novartis) Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.4.5 Sandoz (Novartis) Key News & Latest Developments
7.5 Hikma Pharmaceuticals PLC
7.5.1 Hikma Pharmaceuticals PLC Company Summary
7.5.2 Hikma Pharmaceuticals PLC Business Overview
7.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Major Product Offerings
7.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.5.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.6 Dr. Reddy?s Laboratories Ltd
7.6.1 Dr. Reddy?s Laboratories Ltd Company Summary
7.6.2 Dr. Reddy?s Laboratories Ltd Business Overview
7.6.3 Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Major Product Offerings
7.6.4 Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.6.5 Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
7.7 Grifols
7.7.1 Grifols Company Summary
7.7.2 Grifols Business Overview
7.7.3 Grifols Hospital Injectable Drugs Major Product Offerings
7.7.4 Grifols Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.7.5 Grifols Key News & Latest Developments
7.8 Nichi-Iko Group (Sagent)
7.8.1 Nichi-Iko Group (Sagent) Company Summary
7.8.2 Nichi-Iko Group (Sagent) Business Overview
7.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Major Product Offerings
7.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.8.5 Nichi-Iko Group (Sagent) Key News & Latest Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Company Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Key News & Latest Developments
7.10 Otsuka
7.10.1 Otsuka Company Summary
7.10.2 Otsuka Business Overview
7.10.3 Otsuka Hospital Injectable Drugs Major Product Offerings
7.10.4 Otsuka Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.10.5 Otsuka Key News & Latest Developments
7.11 B.Braun
7.11.1 B.Braun Company Summary
7.11.2 B.Braun Business Overview
7.11.3 B.Braun Hospital Injectable Drugs Major Product Offerings
7.11.4 B.Braun Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.11.5 B.Braun Key News & Latest Developments
7.12 JW Life Science
7.12.1 JW Life Science Company Summary
7.12.2 JW Life Science Business Overview
7.12.3 JW Life Science Hospital Injectable Drugs Major Product Offerings
7.12.4 JW Life Science Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.12.5 JW Life Science Key News & Latest Developments
7.13 Auromedics
7.13.1 Auromedics Company Summary
7.13.2 Auromedics Business Overview
7.13.3 Auromedics Hospital Injectable Drugs Major Product Offerings
7.13.4 Auromedics Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.13.5 Auromedics Key News & Latest Developments
7.14 Sanofi
7.14.1 Sanofi Company Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Hospital Injectable Drugs Major Product Offerings
7.14.4 Sanofi Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.14.5 Sanofi Key News & Latest Developments
7.15 Gland Pharma
7.15.1 Gland Pharma Company Summary
7.15.2 Gland Pharma Business Overview
7.15.3 Gland Pharma Hospital Injectable Drugs Major Product Offerings
7.15.4 Gland Pharma Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.15.5 Gland Pharma Key News & Latest Developments
7.16 Endo International PLC
7.16.1 Endo International PLC Company Summary
7.16.2 Endo International PLC Business Overview
7.16.3 Endo International PLC Hospital Injectable Drugs Major Product Offerings
7.16.4 Endo International PLC Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.16.5 Endo International PLC Key News & Latest Developments
7.17 Sichuan Kelun Pharmaceutical
7.17.1 Sichuan Kelun Pharmaceutical Company Summary
7.17.2 Sichuan Kelun Pharmaceutical Business Overview
7.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.17.5 Sichuan Kelun Pharmaceutical Key News & Latest Developments
7.18 Cisen Pharmaceutical
7.18.1 Cisen Pharmaceutical Company Summary
7.18.2 Cisen Pharmaceutical Business Overview
7.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.18.5 Cisen Pharmaceutical Key News & Latest Developments
7.19 Shijiazhuang No. 4 Pharmaceutical
7.19.1 Shijiazhuang No. 4 Pharmaceutical Company Summary
7.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
7.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.19.5 Shijiazhuang No. 4 Pharmaceutical Key News & Latest Developments
7.20 Shandong Hualu Pharmaceutical
7.20.1 Shandong Hualu Pharmaceutical Company Summary
7.20.2 Shandong Hualu Pharmaceutical Business Overview
7.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.20.5 Shandong Hualu Pharmaceutical Key News & Latest Developments
7.21 CR Double-Crane
7.21.1 CR Double-Crane Company Summary
7.21.2 CR Double-Crane Business Overview
7.21.3 CR Double-Crane Hospital Injectable Drugs Major Product Offerings
7.21.4 CR Double-Crane Hospital Injectable Drugs Revenue in Global Market (2018-2023)
7.21.5 CR Double-Crane Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital Injectable Drugs Market Opportunities & Trends in Global Market
Table 2. Hospital Injectable Drugs Market Drivers in Global Market
Table 3. Hospital Injectable Drugs Market Restraints in Global Market
Table 4. Key Players of Hospital Injectable Drugs in Global Market
Table 5. Top Hospital Injectable Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital Injectable Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital Injectable Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital Injectable Drugs Product Type
Table 9. List of Global Tier 1 Hospital Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hospital Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hospital Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hospital Injectable Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital Injectable Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Hospira (Pfizer Inc.) Company Summary
Table 31. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offerings
Table 32. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Hospira (Pfizer Inc.) Key News & Latest Developments
Table 34. Baxter Company Summary
Table 35. Baxter Hospital Injectable Drugs Product Offerings
Table 36. Baxter Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Baxter Key News & Latest Developments
Table 38. Fresenius Kabi Company Summary
Table 39. Fresenius Kabi Hospital Injectable Drugs Product Offerings
Table 40. Fresenius Kabi Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Fresenius Kabi Key News & Latest Developments
Table 42. Sandoz (Novartis) Company Summary
Table 43. Sandoz (Novartis) Hospital Injectable Drugs Product Offerings
Table 44. Sandoz (Novartis) Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sandoz (Novartis) Key News & Latest Developments
Table 46. Hikma Pharmaceuticals PLC Company Summary
Table 47. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offerings
Table 48. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Hikma Pharmaceuticals PLC Key News & Latest Developments
Table 50. Dr. Reddy?s Laboratories Ltd Company Summary
Table 51. Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Product Offerings
Table 52. Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Hospital Injectable Drugs Product Offerings
Table 56. Grifols Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Grifols Key News & Latest Developments
Table 58. Nichi-Iko Group (Sagent) Company Summary
Table 59. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offerings
Table 60. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Nichi-Iko Group (Sagent) Key News & Latest Developments
Table 62. Teva Pharmaceutical Company Summary
Table 63. Teva Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 64. Teva Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Key News & Latest Developments
Table 66. Otsuka Company Summary
Table 67. Otsuka Hospital Injectable Drugs Product Offerings
Table 68. Otsuka Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Otsuka Key News & Latest Developments
Table 70. B.Braun Company Summary
Table 71. B.Braun Hospital Injectable Drugs Product Offerings
Table 72. B.Braun Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. B.Braun Key News & Latest Developments
Table 74. JW Life Science Company Summary
Table 75. JW Life Science Hospital Injectable Drugs Product Offerings
Table 76. JW Life Science Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. JW Life Science Key News & Latest Developments
Table 78. Auromedics Company Summary
Table 79. Auromedics Hospital Injectable Drugs Product Offerings
Table 80. Auromedics Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Auromedics Key News & Latest Developments
Table 82. Sanofi Company Summary
Table 83. Sanofi Hospital Injectable Drugs Product Offerings
Table 84. Sanofi Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Sanofi Key News & Latest Developments
Table 86. Gland Pharma Company Summary
Table 87. Gland Pharma Hospital Injectable Drugs Product Offerings
Table 88. Gland Pharma Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Gland Pharma Key News & Latest Developments
Table 90. Endo International PLC Company Summary
Table 91. Endo International PLC Hospital Injectable Drugs Product Offerings
Table 92. Endo International PLC Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Endo International PLC Key News & Latest Developments
Table 94. Sichuan Kelun Pharmaceutical Company Summary
Table 95. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 96. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Sichuan Kelun Pharmaceutical Key News & Latest Developments
Table 98. Cisen Pharmaceutical Company Summary
Table 99. Cisen Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 100. Cisen Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Cisen Pharmaceutical Key News & Latest Developments
Table 102. Shijiazhuang No. 4 Pharmaceutical Company Summary
Table 103. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 104. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Shijiazhuang No. 4 Pharmaceutical Key News & Latest Developments
Table 106. Shandong Hualu Pharmaceutical Company Summary
Table 107. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 108. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Shandong Hualu Pharmaceutical Key News & Latest Developments
Table 110. CR Double-Crane Company Summary
Table 111. CR Double-Crane Hospital Injectable Drugs Product Offerings
Table 112. CR Double-Crane Hospital Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. CR Double-Crane Key News & Latest Developments
List of Figures
Figure 1. Hospital Injectable Drugs Segment by Type in 2022
Figure 2. Hospital Injectable Drugs Segment by Application in 2022
Figure 3. Global Hospital Injectable Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital Injectable Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hospital Injectable Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2022
Figure 8. By Type - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hospital Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hospital Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 16. US Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 28. China Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hospital Injectable Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hospital Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Baxter Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Fresenius Kabi Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sandoz (Novartis) Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Grifols Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Otsuka Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. B.Braun Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. JW Life Science Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Auromedics Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sanofi Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Gland Pharma Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Endo International PLC Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Cisen Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. CR Double-Crane Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
